Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04054 |
| Species: | Homo sapiens |
| Position : | chr2:79272263-79272447 |
| Year: | 2019 |
| Title: | LncRNA REG1CP promotes tumorigenesis through an enhancer complex to recruit FANCJ helicase for REG3A transcription. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | cancer (subtype not defined in abstract) |
| PMID: | 31767869 |
| Tissue: | colon |
| Tissue Ontology ID: | UBERON:0001155 |
| Cell Source: | HT-29 |
| CVCL ID: | CVCL_0320 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Functional perturbation assay |
| High Throughput Method: | RNA-seq, ChIP-seq |
| Low Throughput Method: | Luciferase Reporter Assay, ChIP-RT-qPCR, RT-RT-qPCR, Western blot, EMSA, shRNA Knockdown |
| Target gene : | REG3A |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|